Showing results (1-10 of 148) with videos related to
Sort By:
Pageof 15
Journal of Clinical Pathology|March 28, 1998
Cytokeratin 14 as a marker of squamous differentiation in transitional cell carcinomasP Harnden, J SouthgateLancet (London, England)|August 25, 1999
Expression of cytokeratin 20 redefines urothelial papillomas of the bladderP Harnden, N Mahmood, J SouthgateHistology and Histopathology|April 23, 1999
Cytokeratin expression patterns in normal and malignant urothelium: a review of the biological and diagnostic implicationsJ Southgate, P Harnden, L K TrejdosiewiczBritish Journal of Urology|December 1, 1996
Cytokeratin 20 as an objective marker of urothelial dysplasiaP Harnden, I Eardley, A D Joyce, et al.International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|April 15, 1999
Immunophenotype of transitional metaplasia of the uterine cervixP Harnden, W Kennedy, A C Andrew, et al.International Journal of Cancer|June 19, 2001
Role of p53 in the responses of human urothelial cells to genotoxic damageC P Diggle, E Pitt, P Harnden, et al.Histopathology|August 1, 1995
Cytokeratin 20 expression by non-invasive transitional cell carcinomas: potential for distinguishing recurrent from non-recurrent diseaseP Harnden, A Allam, A D Joyce, et al.BJU International|March 11, 2004
A surgical model of composite cystoplasty with cultured urothelial cells: a controlled study of gross outcome and urothelial phenotypeM Fraser, D F Thomas, E Pitt, et al.Laboratory Investigation; a Journal of Technical Methods and Pathology|June 1, 1997
Stromal and vascular invasion in an human in vitro bladder cancer modelC Booth, P Harnden, L K Trejdosiewicz, et al.Cancer Research|March 14, 2001
Identification of genes involved in human urothelial cell-matrix interactions: implications for the progression pathways of malignant urotheliumB A Smith, W J Kennedy, P Harnden, et al.Pageof 15